Local Study Associate Director @ AstraZeneca | Jobright.ai
JOBSarrow
RecommendedLiked
0
Applied
0
External
0
Local Study Associate Director jobs in Wilmington, DE
Be an early applicantLess than 25 applicants
company-logo

AstraZeneca · 6 hours ago

Local Study Associate Director

ftfMaximize your interview chances
BiopharmaBiotechnology
check
Comp. & Benefits

Insider Connection @AstraZeneca

Discover valuable connections within the company who might provide insights and potential referrals.
Get 3x more responses when you reach out via email instead of LinkedIn.

Responsibilities

Has the overall responsibility for the study commitments within the country and for timely delivery of data to required quality.
Leads Local Study Team consisting of CRA(s), CSA(s), for assigned study/studies
Leads and optimizes the performance of the Local Study Team(s) at country level ensuring compliance with AZ Procedural Documents, ICH-GCP and local regulations.
Ensures, as required, that clinical and operational feasibility assessment of potential studies is performed to the highest quality.
Coordinates the site selection process by identifying potential sites/investigators, performing initial Site Quality Risk Assessment, and conducting Site Qualification Visits to evaluate suitability and quality risks.
Ensures timely submission of application/documents to EC/IRB at start up and for the duration of the study. Works together with Regulatory Affairs to ensure timely delivery of application/documents for submissions to Regulatory Authority for the duration of the study, and in line with local regulations.
Ensures timely preparation of country financial Study Management Agreement and maintains accurate study budget in AZ clinical studies financial system by regular checks of the system and financial reports (as agreed with Director, SMM/ Director, Country Head.
Ensures timely preparation of local Master CSA (including site budget) and amendments as needed.
Ensures all country and site level trial essential documents required by ICH-GCP prior to study start have been collected and verified for correctness, prior to setting sites ready to enrol, and in line with AZ SOPs.
Plans and coordinates applicable local drug activities (from local purchase or reimbursement to drug destruction).
Sets up and maintains the study in CTMS at study country level as well as local websites as required by local laws and regulations.
Oversees, manages and coordinates monitoring activities from site activation through to study closure at country and site level in accordance with the Monitoring Plans.
Reviews monitoring visit reports (as required and following AZ SOPs) and pro-actively advices the monitor(s) on study related matters.
Performs any required co-monitoring, Accompanied Site Visits/training visits with study CRAs.
Proactively identifies risks and facilitates resolution of complex study problems and issues.

Qualification

Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.

HematologyCell TherapyICH-GCPEnglish LanguageDevelopment OperationsProject Management

Required

Bachelor degree in related discipline, preferably in life science
Minimum 3 years of experience in Development Operations (CRA, Sr CRA) or other related fields (Medical Affairs-led or Academic-led studies)
Good knowledge of international guidelines ICH-GCP as well as relevant local regulations
Proven ability to lead and motivate cross-functional teams to deliver clinical trials according to or ahead of time plan, budget and with required quality
Excellent project management skills
Excellent team building and interpersonal skills
Excellent organisational skills
Excellent verbal and written communication skills
Excellent ability to prioritize and handle multiple tasks
Excellent knowledge of spoken and written English
Must Have Experience In Hematology Or Cell Therapy

Company

AstraZeneca

company-logo
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor AB.

Funding

Current Stage
Public Company
Total Funding
$5.27B
2024-07-30Post Ipo Debt· $1.52B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B

Leadership Team

leader-logo
Pascal Soriot
Executive Director and Chief Executive Officer
linkedin
leader-logo
Aradhana Sarin
Executive Director and Chief Financial Officer
linkedin

Recent News

News Powered by Cision
Company data provided by crunchbase
logo

Orion

Your AI Copilot